Aspira Women's Health Inc.
AWHL
$0.27
-$0.03-10.00%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -14.89% | -13.69% | -5.15% | 2.13% | -0.78% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -14.89% | -13.69% | -5.15% | 2.13% | -0.78% |
| Cost of Revenue | 5.17% | 24.62% | -8.14% | 2.22% | -13.17% |
| Gross Profit | -26.27% | -31.35% | -3.43% | 2.07% | 7.95% |
| SG&A Expenses | -13.58% | -45.11% | -47.76% | -46.36% | -45.09% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -7.90% | -24.44% | -39.24% | -35.28% | -38.17% |
| Operating Income | -1.38% | 32.01% | 62.58% | 57.83% | 58.80% |
| Income Before Tax | 9.23% | 136.48% | -142.72% | -37.92% | 24.48% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 9.23% | 136.48% | -142.72% | -37.92% | 24.48% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 9.23% | 136.48% | -142.72% | -37.92% | 24.48% |
| EBIT | -1.38% | 32.01% | 62.58% | 57.83% | 58.80% |
| EBITDA | 0.22% | 32.97% | 62.69% | 58.91% | 58.80% |
| EPS Basic | 27.07% | 118.07% | 5.18% | 41.62% | 73.40% |
| Normalized Basic EPS | 27.08% | 140.59% | -22.93% | 41.63% | 73.38% |
| EPS Diluted | 27.07% | 42.56% | 5.18% | 41.62% | 73.40% |
| Normalized Diluted EPS | 27.08% | 138.49% | -22.93% | 41.63% | 73.38% |
| Average Basic Shares Outstanding | 24.42% | 101.44% | 156.05% | 136.20% | 184.09% |
| Average Diluted Shares Outstanding | 24.42% | 112.01% | 156.05% | 136.20% | 184.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |